Stay updated on ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial page.

Latest updates to the ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 was added to the page, and the footer now removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. These are minor maintenance updates that do not affect the study information or user actions on the page.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedNew revision label v3.3.2 appears in the page history, and the previous v3.2.0 revision is removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe notice regarding lapse in government funding and operating status on the NIH site was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check71 days agoChange DetectedA new version entry was added to the Record History, updating the study's recruitment status and study status.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference12%

- Check100 days agoChange DetectedCore page content updated: recruitment status now active, newer date (2025-09-23) and newer revision (v3.1.0) replace older recruiting status, May 2024 date, and v3.0.2.SummaryDifference3%

Stay in the know with updates to ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial page.